Dr. Mark Davis was enjoying a successful career as a chemical engineer, until his wife was diagnosed with breast cancer. Now, ten years later, he’s created a revolutionary nanoparticle drug that has reversed terminal cancer in one test patient. This story is featured in "Curious," a series co-produced by Thirteen/WNET. Dr. Davis is joined by series producer Mark Mannucci and Ray Natha, the cancer patient featured in the story.
About The Leonard Lopate Show
Host Leonard Lopate lets you in on the best conversations with writers, actors, ex-presidents, dancers, scientists, comedians, historians, grammarians, curators, filmmakers, and do-it-yourself experts.
Hosted by Leonard Lopate
Links
- 2012 Election Coverage
- 25 Years of Lopate
- American History XX
- Backstory
- Food Fridays
- Globavores: Food Travels Around The World Since 1492
- Guest Hosts
- Guest Picks
- Please Explain
- The Gurus of How-To
- The Leonard Lopate Show Book Club
- The Lodown
- The Story of New York in 10 Objects
- Tributes
- Underappreciated
- Underreported
- Web Extras
- Word Maven: Patricia T. O'Conner
Show Archive
Show Archive
Comments [4]
So glad to hear you are reporting on issues like this new cancer therapy, new public tv series and also the grossly underreported humanitarian crises around the world. Thank you!
Check out the clinical trial page...pancreatic cancer is on the list...
http://clinicaltrials.gov/ct/show/NCT00333502?order=1
Has this drug been used to treat pancreatic cancer?
Saw the IT 101 story some time back on PBS...one can only hope that this man is TRULY on to something...fascinating...
Leave a Comment
Register for your own account so you can vote on comments, save your favorites, and more. Learn more.
Please stay on topic, be civil, and be brief.
Email addresses are never displayed, but they are required to confirm your comments. Names are displayed with all comments. We reserve the right to edit any comments posted on this site. Please read the Comment Guidelines before posting. By leaving a comment, you agree to New York Public Radio's Privacy Policy and Terms Of Use.